title: Intravenous β agonists and severe pediatric asthma exacerbation: time for a closer look at terbutaline?
authors.affiliation: Division of Critical Care Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: david.kantor@childrens.harvard.edu.
authors.forename: David B
authors.initials: DB
authors.lastname: Kantor
authors.affiliation: Division of Allergy and Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Wanda
authors.initials: W
authors.lastname: Phipatanakul
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D012131:Respiratory Insufficiency / Q000453:epidemiology*; D013726:Terbutaline / Q000008:administration & dosage*
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D013726:Terbutaline